Phenylalanine monooxygenase and the 'sulfoxidation polymorphism'; the salient points
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
---|---|
Enthalten in: |
Drug metabolism and personalized therapy - 37(2022), 4 vom: 01. Dez., Seite 393-395 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Steventon, Glyn B [VerfasserIn] |
---|
Links: |
---|
Themen: |
47E5O17Y3R |
---|
Anmerkungen: |
Date Completed 15.12.2022 Date Revised 21.12.2022 published: Electronic-eCollection Citation Status MEDLINE |
---|
doi: |
10.1515/dmpt-2021-0233 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM342296310 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM342296310 | ||
003 | DE-627 | ||
005 | 20231226013756.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1515/dmpt-2021-0233 |2 doi | |
028 | 5 | 2 | |a pubmed24n1140.xml |
035 | |a (DE-627)NLM342296310 | ||
035 | |a (NLM)35708245 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Steventon, Glyn B |e verfasserin |4 aut | |
245 | 1 | 0 | |a Phenylalanine monooxygenase and the 'sulfoxidation polymorphism'; the salient points |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.12.2022 | ||
500 | |a Date Revised 21.12.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 4 | |a diurnal variation | |
650 | 4 | |a efficacy | |
650 | 4 | |a enzymology | |
650 | 4 | |a polymorphism | |
650 | 7 | |a Phenylalanine Hydroxylase |2 NLM | |
650 | 7 | |a EC 1.14.16.1 |2 NLM | |
650 | 7 | |a Phenylalanine |2 NLM | |
650 | 7 | |a 47E5O17Y3R |2 NLM | |
700 | 1 | |a Mitchell, Stephen C |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Drug metabolism and personalized therapy |d 2015 |g 37(2022), 4 vom: 01. Dez., Seite 393-395 |w (DE-627)NLM239517768 |x 2363-8915 |7 nnns |
773 | 1 | 8 | |g volume:37 |g year:2022 |g number:4 |g day:01 |g month:12 |g pages:393-395 |
856 | 4 | 0 | |u http://dx.doi.org/10.1515/dmpt-2021-0233 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 37 |j 2022 |e 4 |b 01 |c 12 |h 393-395 |